Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Grail
MedTech
Grail sees Q3 sales jump, eyes Q1 for FDA Galleri PMA submission
Grail saw a sharp rise in third-quarter sales as it outlined a firmer FDA submission date for its Galleri cancer blood test.
Ben Adams
Nov 13, 2025 9:05am
Grail reveals boosted performance data from cancer blood test
Oct 20, 2025 8:40am
Grail plans to submit updated Galleri blood test to FDA in 2026
Jun 18, 2025 11:45am
EU court hands Illumina consolation prize over Grail deal
Sep 3, 2024 12:21pm
Flying solo, Grail to cut 30% of staff, narrow cancer test focus
Aug 14, 2024 11:30am
Grail makes ground in massive U.S., U.K. clinical studies
Jul 17, 2024 10:29am
